newsfilter
← Latest News
GlobeNewswire·

Neurogene and Neoleukin Announce Definitive Merger Agreement

Proposed merger to create Nasdaq-listed biotech company focused on advancing Neurogene's differentiated portfolio of genetic medicines for complex neurological diseases Combined company is expected to have a cash